Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Andrew Last, David Weber

Premium

Affymetrix has appointed Andrew Last to the position of chief operating officer, and named David Weber as its chief commercial officer, the company said in a recent US Securities and Exchange Commission filing.

Last had been executive vice president of Affymetrix's Genetic Analysis business unit, while Weber's previous title was executive vice president of global commercial operations. The company said the organizational changes will enable its CEO Frank Witney to "focus more time on refining the strategic vision and product portfolio of the company as its business continues to diversify and the underlying technologies evolve."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.